If everyone in pharma leadership were more like LM, this job would be a lot more rewarding both professionally and financially. So many lackluster drones in management. LM inspires and treats people with respect. The rest should pay attention and follow along.
If, and most likely it will, as it does not look good good now, the P3 study in fall (Alzheimer’s psychosis) is negative, then BMS is done. CV failure, nothing in oncology and a 14 billion Karuna f..up. No recovery
